A study has found a previously known cancer-related drug can also help slow down the symptoms of Parkinson's disease, but ...

A study found that a diabetes treatment DPP-4 inhibitor prevents Parkinson's disease from progressing.A research team led by ...

ATH434 improves daily function and reduces brain iron in patients with multiple system atrophy, a rare, fatal ...

Most Parkinson's symptoms stem from the loss or dysfunction of dopamine-producing neurons in a brain region involved in fine ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. | ...

As Parkinson's disease progresses, harmful protein clumps build up in the brain, blocking communications between neurons and ...

Researchers have devised a new way to illuminate the previously invisible oligomer clumps driving Parkinson’s disease.

Amsterdam, NL, November 13, 2019 - Aggregates of the protein alpha-synuclein arising in the gut may play a key role in the development of Parkinson's disease (PD). Investigators are testing the ...

A neurodegenerative disorder characterized by the aggregation of alpha synuclein into Lewy bodies in the brain is known as Parkinson’s Disease (PD). Alpha synuclein is a 14-kDa protein encoded by the ...

Studies have uncovered that abnormalities in the alpha-synuclein protein are likely a causal factor for numerous diseases, including Parkinson’s disease, multiple system atrophy (MSA), dementia with ...